LBRX
LBRX
NASDAQ · Pharmaceuticals

Lb Pharmaceuticals Inc

$31.97
-0.01 (-0.03%)
As of May 10, 10:18 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -52.4% upside
Low Target $11.61
Average Target $15.21
High Target $18.52
Current Price $31.97
Current
$31.97
Target
$15.21
$11.61 $15.21 avg $18.52
Scenario Analysis
Bear Case
$11.61
-63.7%
Low target
Base Case
$15.21
-52.4%
Avg target
Bull Case
$18.52
+-42.1%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$33.47
-4.5% from high
52-Week Low
$13.36
+139.3% from low
Target vs 52W High
$15.21
-54.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%